MatriSys Focuses On ‘Good Microbe’ Approach To Dermatology, Maybe Skin Cancer Too
Executive Summary
Emerging Company Profile: Calling itself the most advanced microbiome company focused on skin diseases, MatriSys has advanced a proprietary microbe to Phase IIa for atopic dermatitis. The biotech also is eyeing UV-induced cancer, rosacea, acne, psoriasis and bacterial skin infections.